Juvenile Myositis (JM or JDM for Juvenile Dermatomyositis) is a rare autoimmune disease that affects about 5,000 children in...
Juvenile dermatomyositis (JDM) is a systemic, autoimmune inflammatory muscle disorder and vasculopathy that affects children younger than 18 years. JDM primarily affects the skin and the skeletal muscles.
Characteristic findings include Gottron’s papules, a heliotrope rash, calcinosis cutis, and symmetrical, proximal muscle weakness.
Juvenile Myositis (JM), including Juvenile Dermatomyositis (JDM) and Juvenile Polymyositis (JPM), are rare autoimmune conditions which cause inflammation. The inflammation for JPM primarily occurs in the muscles, while in JDM the inflammation is in the blood vessels that lie under the skin and in the muscle tissue. This inflammation causes weak muscles and – in the case of JDM – skin rashes. If blood vessels or muscle cells in other parts of the body are inflamed, other systems of the body can be affected, such as the digestive tract, heart, and lungs. The condition itself and the treatment for the disease can be life-threatening.
Juvenile Dermatomyositis, Inflammation, and Calcifications Autoimmune diseases, when the immune system attacks certain areas of the body, affect more...
Search our site
November 17 @ 2:00 pm - 3:30 pm EST
November 30 @ 4:00 pm - 6:00 pm EST
December 28 @ 4:00 pm - 6:00 pm EST
EULAR/ACR Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups November 5, 2018
Clinical trials and studies require patient groups in c...
Advances in the Early Diagnosis and Therapy of Inclusion Body Myositis October 28, 2018
The purpose of this article is to describe advancements...